The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
dc.contributor.author | An Haack, Ira | |
dc.contributor.author | Derkow, Katja | |
dc.contributor.author | Riehn, Mathias | |
dc.contributor.author | Rentinck, Marc-Nicolas | |
dc.contributor.author | Kühl, Anja A | |
dc.contributor.author | Lehnardt, Seija | |
dc.contributor.author | Schott, Eckart | |
dc.date.accessioned | 2016-07-07T09:30:35Z | |
dc.date.available | 2016-07-07T09:30:35Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis. 2015, 10 (11):e0143715 PLoS ONE | en |
dc.identifier.issn | 1932-6203 | |
dc.identifier.pmid | 26599014 | |
dc.identifier.doi | 10.1371/journal.pone.0143715 | |
dc.identifier.uri | http://hdl.handle.net/10033/615675 | |
dc.description.abstract | The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It remains disputed whether Treg suppress T cell-mediated hepatitis in vivo and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis. | |
dc.language.iso | en | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject.mesh | Animals | en |
dc.subject.mesh | CD4-Positive T-Lymphocytes | en |
dc.subject.mesh | Forkhead Transcription Factors | en |
dc.subject.mesh | Hepatitis, Autoimmune | en |
dc.subject.mesh | Interleukin-2 Receptor alpha Subunit | en |
dc.subject.mesh | Liver | en |
dc.subject.mesh | Mice | en |
dc.subject.mesh | T-Lymphocytes, Regulatory | en |
dc.title | The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis. | en |
dc.type | Article | en |
dc.contributor.department | Dept. of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Berlin, Germany. | en |
dc.identifier.journal | PloS one | en |
refterms.dateFOA | 2018-06-13T19:57:10Z | |
html.description.abstract | The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It remains disputed whether Treg suppress T cell-mediated hepatitis in vivo and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis. |